Skip to main content

Table 2 Summary of dose coverage of the PTVs

From: Radiotherapy of nasopharyngeal cancer using Rapidarc: dosimetric study of military teaching hospital Mohamed V, Morocco

Target volume

Parameter

Objective

Mean ± SD

PTV HR

PTV HR (cm3)

 

241.11 ± 144.6

D2%

 

105.17 ± 2.32

D5%

 

104.6 ± 2.16

D95%

 

97.21 ± 1.5

D98%

 

94.74 ± 3.4

V95% (cm3)

 

236.32 ± 142.38

HI2

1

1.08 ± 0.02

HI5

1

1.08 ± 0.02

HI

0

0.08 ± 0.02

CI

1

0.98 ± 0.02

PTV IR

VPTV IR (cm3)

 

488.51 ± 252.12

D2%

 

104.47 ± 2.2

D5%

 

103.8 ± 2.1

D95%

 

97.5 ± 3.3

D98%

 

95 ± 3.9

V95% (cm3)

 

316.35 ± 218.72

HI2

1

1.22 ± 0.05

HI5

1

1.18 ± 0.04

PTV LR

VPTV LR (cm3)

 

667.15 ± 335

D2%

 

101.84 ± 7.08

D5%

 

100.89 ± 7.26

D95%

 

97.10 ± 6.86

D98%

 

92.67 ± 14.56

V95% (cm3)

 

269.17 ± 201.2

HI2

1

1.5 ± 0.81

HI5

1

1.3 ± 0.16